Log in to save to my catalogue

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_iop_journals_10_1088_2515_7620_ad9818

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

About this item

Full title

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

Publisher

Bristol: IOP Publishing

Journal title

Environmental Research Communications, 2024-12, Vol.6 (12), p.125009

Language

English

Formats

Publication information

Publisher

Bristol: IOP Publishing

More information

Scope and Contents

Contents

Background
. In recent years, greenhouse gas (GHG) emissions from inhalers have received more attention. The inhalers are classified as controllers and relievers, which are mainly short-acting beta-agonists (SABA), and SABAs account for more than 50% of all inhaler use in most countries. The overuse of SABA is common in asthma patients, but the...

Alternative Titles

Full title

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_iop_journals_10_1088_2515_7620_ad9818

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_iop_journals_10_1088_2515_7620_ad9818

Other Identifiers

ISSN

2515-7620

E-ISSN

2515-7620

DOI

10.1088/2515-7620/ad9818

How to access this item